Gyermekkori daganatok: vizsgálatok itt: Kína
611 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisNot yet taking people in KínaFollow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1
- Where
- Shanghai
- Életkor
- 2 év to 20 év
- People
- 65
- Run by
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
See details and how to joinNCT07024394 - 2. fázisNot yet taking people in KínaNeoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer
- Where
- Beijing
- Életkor
- 16 év to 45 év
- People
- 35
- Run by
- zhoujing
See details and how to joinNCT07018063 - No phaseTaking peopleThe Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study
- Where
- Guangzhou
- Életkor
- 1 év to 18 év
- People
- 60
- Run by
- Sun Yat-sen University
See details and how to joinNCT04957901 - 2. fázisTaking peopleHigh-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma
- Where
- Chengdu
- Életkor
- 16 év to 70 év
- People
- 34
- Run by
- Sichuan University
See details and how to joinNCT07014943 - No phaseTaking peopleJY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
- Where
- Guangzhou
- Életkor
- 12 év to 75 év
- People
- 20
- Run by
- Affiliated Hospital of Guangdong Medical University
See details and how to joinNCT06940960 - 2. fázisTaking peopleVenetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
- Where
- Suzhou
- Életkor
- 14 év and over
- People
- 32
- Run by
- yuejun Liu
See details and how to joinNCT07012447 - 1/2. fázisTaking peopleEfficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
- Where
- Shanghai
- Életkor
- 2 év to 75 év
- People
- 50
- Run by
- Shanghai Tongji Hospital, Tongji University School of Medicine
See details and how to joinNCT06987916 - 2. fázisTaking peopleInterferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
- Where
- Beijing
- Életkor
- 12 év to 65 év
- People
- 35
- Run by
- Peking University People's Hospital
See details and how to joinNCT06130579 - No phaseTaking peopleEnucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery
- Where
- Hangzhou
- Életkor
- 14 év to 70 év
- People
- 30
- Run by
- Zhejiang University
See details and how to joinNCT06164769 - No phaseTaking peopleContrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
- Where
- Chongqing
- People
- 800
- Run by
- Mingzhao Xiao
See details and how to joinNCT06088134 - No phaseTaking peopleDeep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer
- Where
- Chongqing
- People
- 500
- Run by
- First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT06092450 - 2. fázisCsak meghívásosStudy on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis
- Where
- Zhengzhou
- Életkor
- Up to 75 év
- People
- 216
- Run by
- Yingjuan Zheng
See details and how to joinNCT06999148 - 1/2. fázisCsak meghívásosEfficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia
- Where
- Tianjin
- Életkor
- 14 év to 55 év
- People
- 80
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT03031249 - 1/2. fázisTaking peopleOlverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML
- Where
- Tianjin
- Életkor
- 15 év and over
- People
- 29
- Run by
- Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06757855 - No phaseTaking peopleIntravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
- Where
- Hefei
- Életkor
- 3 év and over
- People
- 18
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06961669 - No phaseTaking peopleA Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)
- Where
- Beijing
- Életkor
- 18 hónap and over
- People
- 300
- Run by
- Peking University First Hospital
See details and how to joinNCT06991868 - No phaseTaking peopleIntraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery
- Where
- Fuzhou
- People
- 100
- Run by
- Fujian Medical University
See details and how to joinNCT06254859 - 2/3. fázisTaking peopleMolecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
- Where
- Shanghai
- Életkor
- 14 év to 75 év
- People
- 126
- Run by
- Ruijin Hospital
See details and how to joinNCT06972641 - No phaseTaking peopleImproved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes
- Where
- Fuzhou
- People
- 300
- Run by
- First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT06977906 - No phaseNot yet taking people in KínaInvestigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors
- Where
- Guangzhou
- People
- 40
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT06979115 - Korai 1. fázisTaking peopleUTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.
- Where
- Hefei
- Életkor
- 3 év to 70 év
- People
- 10
- Run by
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT06092047 - No phaseCsak meghívásosRisk Model for Metastasis Detection of Neuroblastoma
- Where
- Hangzhou, Shanghai, Shenzhen
- People
- 500
- Run by
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06703944 - 2. fázisTaking peopleSafety and Efficacy of Pucotenlimab in pLECC
- Where
- Guangzhou
- Életkor
- 1 év to 18 év
- People
- 33
- Run by
- Sun Yat-sen University
See details and how to joinNCT06969534 - Korai 1. fázisTaking peopleHigh-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
- Where
- Shanghai
- Életkor
- 1 év to 12 év
- People
- 10
- Run by
- Eye & ENT Hospital of Fudan University
See details and how to joinNCT06972602 - 2. fázisTaking peopleBIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma
- Where
- Shanghai
- Életkor
- 8 év to 65 év
- People
- 30
- Run by
- Ruijin Hospital
See details and how to joinNCT04072042